Table 1.

Demographic and clinical characteristics of study participants (n=16)

Sample characteristics, third interview	Description
Gender
Male	9 (56%)
Female	7 (44%)
Age (years)	Mean 55.1; range up to 75)
<60	8 (50%)
≥60	8 (50%)
Marital status
Married or common-law relationship	13 (81%)
Single/divorced	3 (19%)
Education
Unskilled workers	2 (12%)
Skilled workers	10 (63%)
Further education	4 (25%)
Diagnosis*
Acute myeloid leukaemia (AML)	11 (69%) (3 relapse)
Chronic myeloid leukaemia in myeloid blast crisis (CML)	1 (6%)
Chronic myelomonocytic leukaemia (CMML)	1 (6%)
Refractory anaemia with excess blasts (RAEB)	1 (6%)
Acute lymphoblastic leukaemia (ALL)	2 (13%)
Time from diagnosis to third interview (weeks)	Mean 51.9; range 40–72
Treatment status
Outpatient Clinic follow-up, Odense University Hospital	3 (19%)
Allogenic haematopoietic stem cell transplantation, National University Hospital, Copenhagen or Aarhus University Hospital	10 (62%)
Second line therapy, Odense University Hospital	3 (19%)

The CML, CMML and RAEB special leukaemia diagnoses, which are chronic diseases, but often turn into acute leukaemia after a short time. Therefore, they received treatment equivalent to acute leukaemia patients’ regiments and were handled identically to them.